Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ali Rihani

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Plos One|August 27, 2013
Effective Alu repeat based RT-Qpcr normalization in cancer cell perturbation experimentsAli Rihani, Tom Van Maerken, Filip Pattyn, et al.
Scientific Reports|May 18, 2018
Expressed repetitive elements are broadly applicable reference targets for normalization of reverse transcription-qPCR data in miceMarjolijn Renard, Suzanne Vanhauwaert, Marine Vanhomwegen, et al.
Journal of the National Cancer Institute|November 12, 2009
Antitumor activity of the selective MDM2 antagonist nutlin-3 against chemoresistant neuroblastoma with wild-type p53Tom Van Maerken, Liesbeth Ferdinande, Jasmien Taildeman, et al.
Plos One|December 16, 2014
CASP8 SNP D302H (rs1045485) is associated with worse survival in MYCN-amplified neuroblastoma patientsAli Rihani, Bram De Wilde, Fjoralba Zeka, et al.
Pediatric Blood & Cancer|January 7, 2014
Lack of association between MDM2 promoter SNP309 and clinical outcome in patients with neuroblastomaAli Rihani, Tom Van Maerken, Bram De Wilde, et al.
Cancer Research|February 6, 2020
Thermal Proteome Profiling Identifies Oxidative-Dependent Inhibition of the Transcription of Major Oncogenes as a New Therapeutic Mechanism for Select Anticancer CompoundsSylvain Peuget, Jiawei Zhu, Gema Sanz, et al.
Cancers|April 30, 2021
A G316A Polymorphism in the Ornithine Decarboxylase Gene Promoter Modulates MYCN-Driven Childhood NeuroblastomaLaura D Gamble, Stefania Purgato, Michelle J Henderson, et al.
Nature Methods|November 1, 2013
The need for transparency and good practices in the qPCR literatureStephen A Bustin, Vladimir Benes, Jeremy Garson, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Plos One|August 27, 2013
Effective Alu repeat based RT-Qpcr normalization in cancer cell perturbation experimentsAli Rihani, Tom Van Maerken, Filip Pattyn, et al.
Scientific Reports|May 18, 2018
Expressed repetitive elements are broadly applicable reference targets for normalization of reverse transcription-qPCR data in miceMarjolijn Renard, Suzanne Vanhauwaert, Marine Vanhomwegen, et al.
Journal of the National Cancer Institute|November 12, 2009
Antitumor activity of the selective MDM2 antagonist nutlin-3 against chemoresistant neuroblastoma with wild-type p53Tom Van Maerken, Liesbeth Ferdinande, Jasmien Taildeman, et al.
Plos One|December 16, 2014
CASP8 SNP D302H (rs1045485) is associated with worse survival in MYCN-amplified neuroblastoma patientsAli Rihani, Bram De Wilde, Fjoralba Zeka, et al.
Pediatric Blood & Cancer|January 7, 2014
Lack of association between MDM2 promoter SNP309 and clinical outcome in patients with neuroblastomaAli Rihani, Tom Van Maerken, Bram De Wilde, et al.
Cancer Research|February 6, 2020
Thermal Proteome Profiling Identifies Oxidative-Dependent Inhibition of the Transcription of Major Oncogenes as a New Therapeutic Mechanism for Select Anticancer CompoundsSylvain Peuget, Jiawei Zhu, Gema Sanz, et al.
Cancers|April 30, 2021
A G316A Polymorphism in the Ornithine Decarboxylase Gene Promoter Modulates MYCN-Driven Childhood NeuroblastomaLaura D Gamble, Stefania Purgato, Michelle J Henderson, et al.
Nature Methods|November 1, 2013
The need for transparency and good practices in the qPCR literatureStephen A Bustin, Vladimir Benes, Jeremy Garson, et al.
Pageof 2